NYSE:AKER

Delisted

Akers Biosciences Stock News

Buy AKER

*Your capital is at risk

$3.81

+0 (+0%)

At Close: Jul 20, 2022

Aker Drops After More Ghana Oil Delays

11:39am, Friday, 01'st Nov 2019

Billionaire Kjell Inge Rokke's Aker ASA dropped the most in 2 1/2 months after saying its oil venture in Ghana is facing more delays due to regulatory chal…

Akers Bioscience S-1 Shows Registration For $7.5M Common Stock, Warrants Offering

12:00am, Friday, 01'st Nov 2019

Stocks That Hit 52-Week Lows On Tuesday

12:00am, Tuesday, 29'th Oct 2019

Income Producing Asset Portfolio Update

12:00am, Thursday, 17'th Oct 2019

The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings

12:00am, Tuesday, 15'th Oct 2019

AKER: Final Settlement Hearing Rescheduled to December —…, —…–9

12:00am, Wednesday, 25'th Sep 2019

Akers Biosciences Q2 Cash, Restricted Cash, Marketable Securities $4.39M

12:00am, Thursday, 15'th Aug 2019

16 Healthcare Stocks Moving In Tuesday's Pre-Market Session

12:00am, Tuesday, 13'th Aug 2019

The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer

12:00am, Tuesday, 04'th Jun 2019

Akers Biosciences Q1 EPS $(0.07) Up From $(0.21) YoY, Sales $612.123K Up From $302.475K YoY

12:00am, Monday, 20'th May 2019

Akers Biosciences Reports Fiscal Year —…–8 Earnings

12:00am, Monday, 01'st Apr 2019

Factors of Influence in —…–9, Key Indicators and Opportunity within ARRIS International ...

12:00am, Friday, 22'nd Feb 2019

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

12:00am, Friday, 21'st Dec 2018

Akers Biosciences Stock News

Aker Drops After More Ghana Oil Delays

Akers Bioscience S-1 Shows Registration For $7.5M Common Stock, Warrants Offering

Stocks That Hit 52-Week Lows On Tuesday

Income Producing Asset Portfolio Update

The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings

AKER: Final Settlement Hearing Rescheduled to December —…, —…–9

Akers Biosciences Q2 Cash, Restricted Cash, Marketable Securities $4.39M

16 Healthcare Stocks Moving In Tuesday's Pre-Market Session

The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer

Akers Biosciences Q1 EPS $(0.07) Up From $(0.21) YoY, Sales $612.123K Up From $302.475K YoY

Akers Biosciences Reports Fiscal Year —…–8 Earnings

Factors of Influence in —…–9, Key Indicators and Opportunity within ARRIS International ...

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum

Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018

Top Fintech Company